Antipodes Partners’s HCA Healthcare HCA Stock Holding History

Antipodes Partners’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$113M	Sell	289,941 -1,511	-0.5%	-$639K	2.07%	18
2026 Q1	$138M	Sell	291,452 -3,068	-1%	-$1.54M	2.66%	11
2025 Q4	$138M	Sell	294,520 -67,659	-19%	-$31.4M	2.89%	10
2025 Q3	$154M	Sell	362,179 -29,279	-7%	-$11.3M	3.46%	6
2025 Q2	$150M	Sell	391,458 -43,965	-10%	-$15.8M	4.65%	6
2025 Q1	$150M	Buy	435,423 +406,682	+1,415%	+$131M	4.71%	7
2024 Q4	$8.63M	Buy	+28,741	New	+$10M	0.3%	38

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

CAM

Crake Asset Management London, United Kingdom $4.18B AUM 13.97% 1-Year Est. Return

Metropolis Capital Amersham, United Kingdom $3.45B AUM 1.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Antipodes Partners's HCA Position: Q2 2026 in Review

Antipodes Partners reduced its HCA Healthcare (HCA) stake by 0.52% in Q2 2026, selling an estimated $639K and leaving 289,941 shares worth $113M. The position accounts for 2.07% of the portfolio, ranked #18.

Antipodes Partners first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $154M in Q3 2025. 819 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Antipodes Partners held 289,941 shares of HCA Healthcare worth $113M as of Q2 2026.
Antipodes Partners sold 1,511 HCA Healthcare shares in Q2 2026, an estimated $639K.
HCA Healthcare made up 2.07% of Antipodes Partners's portfolio in Q2 2026, its #18 holding.
Antipodes Partners first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
Antipodes Partners's HCA Healthcare position peaked at $154M in Q3 2025.
819 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.